Pandori M, Craig H, Moutouh L, Corbeil J, Guatelli J
Department of Medicine, Department of Pathology, Department of Veterans Affairs Medical Center, San Diego, California, USA.
Virology. 1998 Nov 25;251(2):302-16. doi: 10.1006/viro.1998.9407.
The HIV-1 Nef protein is present within the virion and is processed there by the viral protease. Mutational analysis indicated that residues 54-60 in HIV-1 Nef were required for intravirion cleavage. When viruses were produced using T cell lines or primary lymphoblasts, these residues were also required for optimal viral infectivity. However, substitution of native Nef residues with those of a functional Gag cleavage site demonstrated that intravirion cleavage was insufficient for the virological function of this domain. Furthermore, the importance of certain cleavage site residues to infectivity was conditional on the producer cell type. In particular, a mutant containing a deletion of residues 54-57 was phenotypically nef defective when produced using T cells (CEM, A2.01, or primary lymphoblasts) but was minimally impaired when produced from 293 or HeLa cells. This mutant was cleavage resistant, indicating that proteolytic processing of Nef was dispensable for infectivity enhancement when virions were assembled in certain non-T cells. Residues 54-61 of the cleavage site, including 54-57, were also required for Nef-mediated down-regulation of CD4. However, the surface expression of CD4 on HeLa cells in amounts comparable to that on the surface of primary T lymphoblasts did not create a producer cell environment in which residues 54-57 acquired greater virological importance. Furthermore, these residues were required for optimal infectivity even during virion assembly in T cells (A2. 01) that expressed a CD4 molecule that is unable to respond to Nef. These data suggested that in producer T cells, certain cleavage site residues (54-57) contribute to a Nef-mediated virological effect that is unlikely to be linked causally to CD4 down-regulation. Conversely, in the context of 293 cells as viral producers, the Delta54-57 mutant separated genetically down-regulation of CD4 (for which it was defective) from enhancement of infectivity (for which it was functional). Together, these data indicate that the virological function of the cleavage site domain is both independent of intravirion proteolytic processing of Nef and independent of CD4 down-regulation.
HIV-1 Nef蛋白存在于病毒颗粒中,并在那里被病毒蛋白酶加工处理。突变分析表明,HIV-1 Nef中54 - 60位氨基酸残基是病毒颗粒内切割所必需的。当使用T细胞系或原代淋巴母细胞产生病毒时,这些残基对于最佳病毒感染性也是必需的。然而,用功能性Gag切割位点的残基替代天然Nef残基表明,病毒颗粒内切割对于该结构域的病毒学功能是不够的。此外,某些切割位点残基对感染性的重要性取决于产生病毒的细胞类型。特别地,一个缺失54 - 57位氨基酸残基的突变体,当使用T细胞(CEM、A2.01或原代淋巴母细胞)产生时,表型上是Nef缺陷型,但从293或HeLa细胞产生时,其受损程度最小。该突变体具有切割抗性,表明当病毒颗粒在某些非T细胞中组装时,Nef的蛋白水解加工对于感染性增强是可有可无的。切割位点的54 - 61位氨基酸残基,包括54 - 57位,对于Nef介导的CD4下调也是必需的。然而,HeLa细胞表面CD4的表达量与原代T淋巴母细胞表面相当,并没有创造出一个使54 - 57位氨基酸残基具有更大病毒学重要性的产生病毒的细胞环境。此外,即使在表达对Nef无反应的CD4分子的T细胞(A2.01)中进行病毒颗粒组装时,这些残基对于最佳感染性也是必需的。这些数据表明,在产生病毒的T细胞中,某些切割位点残基(54 - 57)促成了一种Nef介导的病毒学效应,这种效应不太可能与CD4下调有因果联系。相反,在以293细胞作为病毒产生细胞的情况下,Delta54 - 57突变体在基因上分离了CD4下调(它在这方面有缺陷)和感染性增强(它在这方面有功能)。总之,这些数据表明切割位点结构域的病毒学功能既独立于Nef在病毒颗粒内的蛋白水解加工,也独立于CD4下调。